Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...

LONDON and NEW YORK, Jan. 23, 2026), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseas ...

OMAHA, NE - January 21, 2026 - PRESSADVANTAGE - Kugler Vision has released a new educational article titled "SMILE vs ...

When our practice adopted the Light Adjustable Lens in 2022, we did so with a clear purpose of helping patients with corneal ...

Henderson, NV - January 16, 2026 - PRESSADVANTAGE - Las Vegas Eye Institute announces the integration of Ray-Traced ...

He consults at Nuffield Health Leeds and Nuffield Health York. Arrange an in-person or video consultation at mrkailasmunot.co ...

Doctors offer tips on how to maintain eye health during glaucoma awareness month ...

Stress urinary incontinence affects up to one in three women worldwide, but the most commonly used treatment has led to ...

The mother has issued a warning to parents as her son now needs multiple surgeries in hopes of returning his vision ...

A common eye surgery gel is restoring sight in people with hypotony, a rare eye condition, offering new hope for vision ...